Small Cap U.S. Stocks with Positive and Negative News Sentiment on July 5, 2023
On July 5, 2023, several small cap U.S. stocks appeared in the news, with some generating positive sentiment and others negative.
Positive Sentiment
- Atara Biotherapeutics (ATRA): Atara announced positive data from a Phase 2 trial of its lead asset, AT-101, in patients with relapsed or refractory multiple myeloma. The data showed that AT-101 was well-tolerated and significantly improved overall survival compared to standard of care.
- Spero Therapeutics (SPRO): Spero announced positive data from a Phase 2 trial of its lead asset, SPR020, in patients with complicated urinary tract infections. The data showed that SPR020 was effective in clearing infections and had a favorable safety profile.
- Alector (ALEC): Alector announced positive data from a Phase 1 trial of its lead asset, AL003, in patients with Alzheimer’s disease. The data showed that AL003 was well-tolerated and had the potential to slow the progression of Alzheimer’s disease.
Negative Sentiment
- Alnylam Pharmaceuticals (ALNY): Alnylam announced that the FDA had placed a clinical hold on its Phase 3 trial of vutrisiran, a potential treatment for hereditary transthyretin amyloidosis. The hold was put in place due to concerns about the safety of vutrisiran.
- Triterras (TRIT): Triterras announced that it had received a subpoena from the SEC. The subpoena is related to Triterras’s relationship with a former employee who is accused of insider trading.
- Arlo Technologies (ARLO): Arlo announced that it had been downgraded by analysts at Morgan Stanley. The downgrade was due to concerns about Arlo’s slowing growth and increasing competition.
It is important to note that these are just a few of the many small cap U.S. stocks that appeared in the news on July 5, 2023. The sentiment of the news stories and the impact on stock prices may vary depending on the individual stock.
Title: Small Cap U.S. Stocks with Positive and Negative News Sentiment on July 5, 2023